Updated September 2026 · Solutions
Telehealth peptides, under your brand
MyOrbitHealth powers peptide telehealth programs the legal way: prescribed compounded peptides, evaluated and prescribed by providers licensed in the patient's state, filled by state-licensed 503A compounding pharmacy partners inside a LegitScript-certified network. You own the brand, the audience, and the customer relationship; we run the providers, intake, e-prescribing, pharmacy routing, and the MSO compliance structure behind it.
What telehealth peptides actually require
Peptides marketed for human use are prescription products, not supplements. A compliant program needs four layers working together, and a brand can own none of them directly.
Licensed prescribers
A provider licensed in the patient's state reviews intake, makes a clinical decision, and prescribes only when appropriate. MyOrbitHealth covers all 50 states with 1,240+ board-certified providers.
503A pharmacy partners
Patient-specific compounded peptides are dispensed by state-licensed 503A pharmacies. OrbitRx routes prescriptions via Surescripts into a LegitScript-certified pharmacy network.
Eligibility tracking
Which peptides may be compounded changes over time. Formularies are clinician-governed and reviewed against current FDA compounding lists rather than fixed at launch.
MSO structure
A non-clinician brand cannot practice medicine. The MSO / friendly-PC structure keeps clinical control with the professional entity while you own brand, marketing, and customers.
Modality rules per state
Some states require a synchronous visit before certain prescribing. Orbit Intake maps modality requirements per state so patient flow stays compliant automatically.
Ad-platform certification
LegitScript certification is effectively required before Google and Meta will run prescription-adjacent campaigns. We support your brand's certification path.
Legal prescription route vs the gray market
The difference is not marketing language. It is whether a prescriber and a licensed pharmacy sit in the chain.
| Clinical decision | Prescription route: a licensed provider evaluates every patient. Gray market: no provider, vials labeled 'research use only' and marketed with dosing protocols anyway. |
|---|---|
| Fulfillment | Prescription route: state-licensed 503A compounding pharmacy. Gray market: unlicensed reseller with no pharmacy oversight. |
| Payments and ads | Prescription route: processors and ad platforms will work with a LegitScript-certified operation. Gray market: frozen merchant accounts and ad bans are routine. |
| Durability | Prescription route: a company you can scale, raise on, and sell. Gray market: enforcement risk that compounds with every new customer. |
What MyOrbitHealth runs for your peptide brand
You keep the brand, the audience, and the customer relationship. We operate the regulated back end.
Orbit Intake
AI-driven adaptive medical intake with severity scoring and red-flag escalation, white-labeled to your brand.
OrbitOS
Clinical console for patients, encounters, prescriptions, and providers, with role-based access and a full HIPAA audit trail.
OrbitRx
EPCS-ready e-prescribing routed via Surescripts into a LegitScript-certified compounding and retail pharmacy network.
Compliance layer
HIPAA with a BAA in every contract, SOC 2 controls, US-region encrypted PHI, and the operating MSO structure.
Room to expand
Peptide customers convert into TRT, HRT, and GLP-1 programs. All of those run on the same stack, so expansion is a config change, not a migration.
Developer path
Run the hosted white-label clinic, or embed care in software you already own through a REST API, webhooks, and a React SDK.
Frequently asked questions
- What are telehealth peptides?
- Telehealth peptides are peptide therapies prescribed through a virtual care visit: a licensed provider reviews the patient's intake and history, prescribes when clinically appropriate, and a state-licensed compounding pharmacy fills and ships the prescription. Peptides marketed for human use are prescription products, not dietary supplements.
- Can I sell peptides under my own brand without a medical license?
- Yes, through an MSO / friendly-PC structure. The affiliated professional entity and its licensed providers hold clinical responsibility and make every prescribing decision, while your company owns the brand, marketing, and customer relationships. You never practice medicine or dispense product yourself.
- Which peptides can be compounded?
- Compounding eligibility is peptide-specific and shifts as FDA compounding lists and pharmacy policies change, so we do not publish a static list. Formularies are clinician-governed and reviewed against current rules, and your program is built so a change in eligibility is a formulary update rather than a business interruption.
- Do you handle the pharmacy relationship?
- Yes. OrbitRx routes prescriptions through Surescripts into a LegitScript-certified pharmacy network spanning 503A compounding and retail, with per-state licensure handled inside the network rather than by your brand.
- How long does a peptide program take to launch?
- Platform configuration typically runs a few weeks. The pacing item is usually LegitScript certification for paid advertising, which commonly takes one to three months, so brands often launch to owned channels first.
Go deeper: are peptides legal?, how to start a peptide business, 503A vs 503B pharmacies, and the best white label telehealth platforms.
This page is general information, not legal or medical advice.
Launch a peptide program on the legal path
Licensed providers in all 50 states, LegitScript-certified pharmacy routing, and an operating MSO structure — under your brand.